Canaan, Vivo Capital, Frazier raising $21.3M for stealth infectious disease startup
The three West Coast venture firms are teaming up to build a stealth new startup called Nexcida Therapeutics. They are developing therapeutics for infectious disease, but haven't disclosed anything else.